{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:55:34Z","timestamp":1770814534747,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T00:00:00Z","timestamp":1737849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T00:00:00Z","timestamp":1737849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s10549-025-07617-6","type":"journal-article","created":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T18:48:54Z","timestamp":1737917334000},"page":"11-22","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Did the COVID-19 consortium recommendations impact the treatment of breast cancer during the COVID-19 pandemic?"],"prefix":"10.1007","volume":"211","author":[{"given":"Marie L.","family":"Fefferman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelley","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Cotler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Bleicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott H.","family":"Kurtzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill M.","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharine","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,26]]},"reference":[{"key":"7617_CR1","unstructured":"CDC. COVID Data Tracker. Centers for Disease Control and Prevention. Published March 28, 2020. Accessed June 19, 2023. https:\/\/covid.cdc.gov\/covid-data-tracker"},{"key":"7617_CR2","unstructured":"Society of Surgical Onoclogy. Resource for Management Options of Breast Cancer During COVID-19. Published online March 30, 2020. https:\/\/www.surgonc.org\/wp-content\/uploads\/2020\/03\/Breast-Resource-during-COVID-19-3.30.20.pdf"},{"key":"7617_CR3","unstructured":"The American Society of Breast Surgeons. ASBrS Resource Guide to Endocrine Therapy in the COVID-19 Pandemic. Published online March 24, 2020. Accessed June 19, 2023. https:\/\/www.breastsurgeons.org\/docs\/statements\/ASBrS-Resource-Guide-on-Endocrine-Therapy-in-the-COVID-19-Pandemic.pdf?v1"},{"key":"7617_CR4","unstructured":"American College of Radiology. ASBrS and ACR Joint Statement on Breast Screening Exams During the COVID-19 Pandemic. Accessed June 19, 2023. https:\/\/www.breastsurgeons.org\/news\/?id=45#:~:text=As%20such%2C%20out%20of%20an,breast%20screening%20exams%20(to%20include"},{"issue":"3","key":"7617_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10549-020-05644-z","volume":"181","author":"JR Dietz","year":"2020","unstructured":"Dietz JR, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, Burstein HJ, Bleicher RJ, Lyons JA, Sarantou T, Baron PL, Stevens RE (2020) Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat 181(3):487\u2013497","journal-title":"Breast Cancer Res Treat"},{"key":"7617_CR6","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1245\/s10434-019-07213-1","volume":"26","author":"K Mallin","year":"2019","unstructured":"Mallin K, Browner A, Palis B, Gay G, McCabe R, Nogueira L, Yabroff R, Shulman L, Facktor M, Winchester DP, Nelson H (2019) Incident cases captured in the National Cancer Database compared with those in US population based central cancer registries in 2012\u20132014. Annal Surg Oncol 26:1604\u20131612","journal-title":"Annal Surg Oncol"},{"issue":"9596","key":"7617_CR7","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453\u20131457","journal-title":"Lancet"},{"issue":"6","key":"7617_CR8","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1245\/s10434-020-08462-1","volume":"27","author":"COVID19 Subcommittee of the O.R. Executive Committee at Memorial Sloan Kettering,","year":"2020","unstructured":"COVID19 Subcommittee of the O.R. Executive Committee at Memorial Sloan Kettering, (2020) Cancer surgery and COVID19. Ann Surg Oncol 27(6):1713\u20131716. https:\/\/doi.org\/10.1245\/s10434-020-08462-1","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"7617_CR9","doi-asserted-by":"publisher","first-page":"e936","DOI":"10.1634\/theoncologist.2020-0213","volume":"25","author":"HO Al-Shamsi","year":"2020","unstructured":"Al-Shamsi HO, Alhazzani W, Alhuraiji A et al (2020) A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group. Oncologist 25(6):e936\u2013e945. https:\/\/doi.org\/10.1634\/theoncologist.2020-0213","journal-title":"Oncologist"},{"issue":"10","key":"7617_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1200\/OP.20.00364","volume":"16","author":"JY Sheng","year":"2020","unstructured":"Sheng JY, Santa-Maria CA, Mangini N et al (2020) Management of breast cancer during the COVID-19 pandemic: a stage- and subtype-specific approach. JCO Oncol Pract 16(10):665\u2013674. https:\/\/doi.org\/10.1200\/OP.20.00364","journal-title":"JCO Oncol Pract"},{"issue":"6","key":"7617_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ccell.2020.05.006","volume":"37","author":"A Harky","year":"2020","unstructured":"Harky A, Chiu CM, Yau THL, Lai SHD (2020) Cancer patient care during COVID-19. Cancer Cell 37(6):749\u2013750. https:\/\/doi.org\/10.1016\/j.ccell.2020.05.006","journal-title":"Cancer Cell"},{"issue":"2","key":"7617_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.5152\/ejbh.2020.240320","volume":"16","author":"A Soran","year":"2020","unstructured":"Soran A, Gimbel M, Diego E (2020) Breast cancer diagnosis, treatment and follow-up during COVID-19 pandemic. Eur J Breast Health 16(2):86\u201388. https:\/\/doi.org\/10.5152\/ejbh.2020.240320","journal-title":"Eur J Breast Health"},{"key":"7617_CR13","unstructured":"Advocacy Resource Center. Factsheet: State action related to delay and resumption of \u201celective\u201d procedures during COVID-19 pandemic. American Medical Association. Published 2020. https:\/\/www.ama-assn.org\/system\/files\/2020-06\/state-elective-procedure-chart.pdf"},{"key":"7617_CR14","unstructured":"American College of Surgeons. COVID-19: Recommendations for Management of Elective Surgical Procedures."},{"key":"7617_CR15","unstructured":"U.S. Government Accountability Office. Medicare Telehealth: Actions Needed to Strengthen Oversight and Help Providers Educate Patients on Privacy and Security Risks. Published online September 26, 2022. https:\/\/www.gao.gov\/products\/gao-22-104454"},{"issue":"9","key":"7617_CR16","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1200\/OP.20.00807","volume":"17","author":"K Hawrot","year":"2021","unstructured":"Hawrot K, Shulman LN, Bleiweiss IJ et al (2021) Time to treatment initiation for breast cancer during the 2020 COVID-19 pandemic. JCO Oncol Pract 17(9):534\u2013540. https:\/\/doi.org\/10.1200\/OP.20.00807","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"7617_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10549-020-05828-7","volume":"184","author":"EL Papautsky","year":"2020","unstructured":"Papautsky EL, Hamlish T (2020) Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic. Breast Cancer Res Treat 184(1):249\u2013254. https:\/\/doi.org\/10.1007\/s10549-020-05828-7","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"7617_CR18","doi-asserted-by":"publisher","first-page":"mzad048","DOI":"10.1093\/intqhc\/mzad048","volume":"35","author":"C Myers","year":"2023","unstructured":"Myers C, Bennett K, Cahir C (2023) Breast cancer care amidst a pandemic: a scoping review to understand the impact of\u00a0coronavirus disease 2019 on\u00a0health services and\u00a0health outcomes. Int J Qual Health Care 35(3):mzad048","journal-title":"Int J Qual Health Care"},{"issue":"6","key":"7617_CR19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s43018-020-0074-y","volume":"1","author":"M Richards","year":"2020","unstructured":"Richards M, Anderson M, Carter P, Ebert BL, Mossialos E (2020) The impact of the COVID-19 pandemic on cancer care. Nat Cancer 1(6):565\u2013567. https:\/\/doi.org\/10.1038\/s43018-020-0074-y","journal-title":"Nat Cancer"},{"issue":"6","key":"7617_CR20","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1001\/jamaoncol.2021.0884","volume":"7","author":"RC Chen","year":"2021","unstructured":"Chen RC, Haynes K, Du S, Barron J, Katz AJ (2021) Association of cancer screening deficit in the United States with the COVID-19 pandemic. JAMA Oncol 7(6):878\u2013884. https:\/\/doi.org\/10.1001\/jamaoncol.2021.0884","journal-title":"JAMA Oncol"},{"issue":"8","key":"7617_CR21","doi-asserted-by":"publisher","first-page":"e1215","DOI":"10.1200\/OP.20.01062","volume":"17","author":"T Satish","year":"2021","unstructured":"Satish T, Raghunathan R, Prigoff JG et al (2021) Care delivery impact of the COVID-19 pandemic on breast cancer care. JCO Oncol Pract 17(8):e1215\u2013e1224. https:\/\/doi.org\/10.1200\/OP.20.01062","journal-title":"JCO Oncol Pract"},{"issue":"8","key":"7617_CR22","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jacr.2022.04.008","volume":"19","author":"LJ Grimm","year":"2022","unstructured":"Grimm LJ, Lee C, Rosenberg RD et al (2022) Impact of the COVID-19 pandemic on breast imaging: an analysis of the national mammography database. J Am Coll Radiol JACR 19(8):919\u2013934. https:\/\/doi.org\/10.1016\/j.jacr.2022.04.008","journal-title":"J Am Coll Radiol JACR"},{"key":"7617_CR23","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6935a2","author":"A Moreland","year":"2020","unstructured":"Moreland A, Herlihy C, Tynan MA et al (2020) Timing of state and territorial COVID-19 stay-at-home orders and changes in population movement\u2014United States, March 1\u2013May 31, 2020. MMWR Morb Mortal Wkly Rep. https:\/\/doi.org\/10.15585\/mmwr.mm6935a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"7617_CR24","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/ijc.33884","volume":"150","author":"T Malag\u00f3n","year":"2022","unstructured":"Malag\u00f3n T, Yong JH, Tope P, Miller WH Jr, Franco EL, McGill Task Force on the Impact of COVID-19 on Cancer Control and Care (2022) Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada. Int J Cancer 150(8):1244\u20131254","journal-title":"Int J Cancer"},{"issue":"8","key":"7617_CR25","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1470-2045(20)30388-0","volume":"21","author":"C Maringe","year":"2020","unstructured":"Maringe C, Spicer J, Morris M et al (2020) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 21(8):1023\u20131034. https:\/\/doi.org\/10.1016\/S1470-2045(20)30388-0","journal-title":"Lancet Oncol"},{"issue":"11","key":"7617_CR26","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/jnci\/djab097","volume":"113","author":"O Alagoz","year":"2021","unstructured":"Alagoz O, Lowry KP, Kurian AW et al (2021) Impact of the COVID-19 pandemic on breast cancer mortality in the US: estimates from collaborative simulation modeling. JNCI J Natl Cancer Inst 113(11):1484\u20131494. https:\/\/doi.org\/10.1093\/jnci\/djab097","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"6","key":"7617_CR27","doi-asserted-by":"publisher","first-page":"e537","DOI":"10.1016\/S2468-2667(22)00090-1","volume":"7","author":"Q Luo","year":"2022","unstructured":"Luo Q, O\u2019Connell DL, Yu XQ et al (2022) Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study. Lancet Public Health 7(6):e537\u2013e548. https:\/\/doi.org\/10.1016\/S2468-2667(22)00090-1","journal-title":"Lancet Public Health"},{"issue":"4","key":"7617_CR28","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1245\/s10434-021-11088-6","volume":"29","author":"JE Tonneson","year":"2022","unstructured":"Tonneson JE, Hoskin TL, Day CN et al (2022) Impact of the COVID-19 pandemic on breast cancer stage at diagnosis, presentation, and patient management. Ann Surg Oncol 29(4):2231\u20132239. https:\/\/doi.org\/10.1245\/s10434-021-11088-6","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"7617_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/0969141320974711","volume":"28","author":"JH Yong","year":"2021","unstructured":"Yong JH, Mainprize JG, Yaffe MJ et al (2021) The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada. J Med Screen 28(2):100\u2013107. https:\/\/doi.org\/10.1177\/0969141320974711","journal-title":"J Med Screen"},{"issue":"3","key":"7617_CR30","doi-asserted-by":"publisher","first-page":"e0213209","DOI":"10.1371\/journal.pone.0213209","volume":"14","author":"AA Khorana","year":"2019","unstructured":"Khorana AA, Tullio K, Elson P et al (2019) Time to initial cancer treatment in the United States and association with survival over time: an observational study. PLoS ONE 14(3):e0213209. https:\/\/doi.org\/10.1371\/journal.pone.0213209","journal-title":"PLoS ONE"},{"issue":"2","key":"7617_CR31","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1245\/s10434-016-5585-5","volume":"24","author":"A Chiba","year":"2017","unstructured":"Chiba A, Hoskin TL, Heins CN, Hunt KK, Habermann EB, Boughey JC (2017) Trends in neoadjuvant endocrine therapy use and impact on rates of breast conservation in hormone receptor-positive breast cancer: a national cancer data base study. Ann Surg Oncol 24(2):418\u2013424. https:\/\/doi.org\/10.1245\/s10434-016-5585-5","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"7617_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10549-022-06634-z","volume":"194","author":"JL Caswell-Jin","year":"2022","unstructured":"Caswell-Jin JL, Shafaee MN, Xiao L et al (2022) Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population. Breast Cancer Res Treat 194(2):475\u2013482. https:\/\/doi.org\/10.1007\/s10549-022-06634-z","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"7617_CR33","first-page":"207","volume":"20","author":"JC Gazet","year":"1994","unstructured":"Gazet JC, Ford HT, Coombes RC et al (1994) Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 20(3):207\u2013214","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"11","key":"7617_CR34","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1001\/jamaoncol.2016.1897","volume":"2","author":"LM Spring","year":"2016","unstructured":"Spring LM, Gupta A, Reynolds KL et al (2016) Neoadjuvant endocrine therapy for estrogen receptor-positive breast cancer: a systematic review and meta-analysis. JAMA Oncol 2(11):1477\u20131486. https:\/\/doi.org\/10.1001\/jamaoncol.2016.1897","journal-title":"JAMA Oncol"},{"issue":"2","key":"7617_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1524-4741.2011.01203.x","volume":"18","author":"U Hille","year":"2012","unstructured":"Hille U, Soergel P, L\u00e4nger F, Schippert C, Makowski L, Hillemanns P (2012) Aromatase inhibitors as solely treatment in postmenopausal breast cancer patients. Breast J 18(2):145\u2013150. https:\/\/doi.org\/10.1111\/j.1524-4741.2011.01203.x","journal-title":"Breast J"},{"issue":"2C","key":"7617_CR36","first-page":"1315","volume":"24","author":"A Milla-Santos","year":"2004","unstructured":"Milla-Santos A, Milla L, Calvo N et al (2004) Anastrozole as neoadjuvant therapy for patients with hormone-dependent, locally-advanced breast cancer. Anticancer Res 24(2C):1315\u20131318","journal-title":"Anticancer Res"},{"issue":"11","key":"7617_CR37","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1023\/a:1013128213451","volume":"12","author":"W Eiermann","year":"2001","unstructured":"Eiermann W, Paepke S, Appfelstaedt J et al (2001) Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study. Ann Oncol Off J Eur Soc Med Oncol 12(11):1527\u20131532. https:\/\/doi.org\/10.1023\/a:1013128213451","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"22","key":"7617_CR38","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1200\/JCO.2005.04.005","volume":"23","author":"IE Smith","year":"2005","unstructured":"Smith IE, Dowsett M, Ebbs SR et al (2005) Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the immediate Preoperative Anastrozole, Tamoxifen, or combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial. J Clin Oncol Off J Am Soc Clin Oncol 23(22):5108\u20135116. https:\/\/doi.org\/10.1200\/JCO.2005.04.005","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"2","key":"7617_CR39","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s12282-021-01302-4","volume":"29","author":"S Roberts","year":"2022","unstructured":"Roberts S, Rojas A, DiRaimo G, Orlando M, Gachabayov M, Castaldi M (2022) Defer surgery in operable breast cancer: how long is too long? Breast Cancer Tokyo Jpn 29(2):224\u2013233. https:\/\/doi.org\/10.1007\/s12282-021-01302-4","journal-title":"Breast Cancer Tokyo Jpn"},{"issue":"3","key":"7617_CR40","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1245\/s10434-021-10883-5","volume":"29","author":"AD Williams","year":"2022","unstructured":"Williams AD, Chang C, Sigurdson ER et al (2022) Neoadjuvant endocrine therapy and delays in surgery for ductal carcinoma in situ: implications for the coronavirus pandemic. Ann Surg Oncol 29(3):1683\u20131691. https:\/\/doi.org\/10.1245\/s10434-021-10883-5","journal-title":"Ann Surg Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07617-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07617-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07617-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T02:05:29Z","timestamp":1743386729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07617-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,26]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["7617"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07617-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,26]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}